0000899243-18-000561.txt : 20180105
0000899243-18-000561.hdr.sgml : 20180105
20180105101100
ACCESSION NUMBER: 0000899243-18-000561
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180104
FILED AS OF DATE: 20180105
DATE AS OF CHANGE: 20180105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Melnick David A.
CENTRAL INDEX KEY: 0001726485
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38266
FILM NUMBER: 18512297
MAIL ADDRESS:
STREET 1: C/O SPERO THERAPEUTICS, INC.
STREET 2: 675 MASSACHUSETTS AVE., 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Spero Therapeutics, Inc.
CENTRAL INDEX KEY: 0001701108
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 MASSACHUSETTS AVENUE
STREET 2: 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-242-1600
MAIL ADDRESS:
STREET 1: 675 MASSACHUSETTS AVENUE
STREET 2: 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Spero Therapeutics, LLC
DATE OF NAME CHANGE: 20170316
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-04
0
0001701108
Spero Therapeutics, Inc.
SPRO
0001726485
Melnick David A.
C/O SPERO THERAPEUTICS, INC.
675 MASSACHUSETTS AVENUE, 14TH FLOOR
CAMBRIDGE
MA
02139
0
1
0
0
Chief Medical Officer
Stock Option (Right to Buy)
12.14
2018-01-04
4
A
0
135000
0.00
A
2028-01-03
Common Stock
135000
135000
D
The shares underlying this option vest as to 25% on January 4, 2019, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
/s/ Leah J. Pollema, Attorney-in-Fact for David A. Melnick
2018-01-05